AR072805A1 - Composiciones intranasales formas galenicas y metodos de tratamiento. - Google Patents
Composiciones intranasales formas galenicas y metodos de tratamiento.Info
- Publication number
- AR072805A1 AR072805A1 ARP090102666A ARP090102666A AR072805A1 AR 072805 A1 AR072805 A1 AR 072805A1 AR P090102666 A ARP090102666 A AR P090102666A AR P090102666 A ARP090102666 A AR P090102666A AR 072805 A1 AR072805 A1 AR 072805A1
- Authority
- AR
- Argentina
- Prior art keywords
- decongestant
- symptoms
- corticosteroid
- condition
- allergic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000000850 decongestant Substances 0.000 abstract 4
- 208000024891 symptom Diseases 0.000 abstract 4
- 239000003246 corticosteroid Substances 0.000 abstract 3
- HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical group CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 abstract 2
- 230000000172 allergic effect Effects 0.000 abstract 2
- 208000010668 atopic eczema Diseases 0.000 abstract 2
- 230000004968 inflammatory condition Effects 0.000 abstract 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical group CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 abstract 2
- 206010028735 Nasal congestion Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960004123 mometasone furoate monohydrate Drugs 0.000 abstract 1
- 229960001528 oxymetazoline Drugs 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 229960000833 xylometazoline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Uso de un descongestionante y un corticosteroide, caracterizado porque es para la manufactura de un medicamento util para el tratamiento o el alivio de uno o más síntomas de una afeccion alérgica o inflamatoria, que comprende una sola administracion diaria. Reivindicacion 8: El uso de la reivindicacion 1, en el cual el descongestionante es oximetazolina. Reivindicacion 13: El uso de la reivindicacion 1, en el cual el corticosteroide es furoato de mometasona monohidrato. Reivindicacion 17: El uso de la reivindicacion 1, en el cual la afeccion de las vías respiratorias superiores es congestion nasal asociada con rinitis alérgica. Reivindicacion 20: El uso de la reivindicacion 1, en el cual el o los síntomas incluyen uno o más síntomas oculares. Reivindicacion 36: Una forma galénica util para tratar o aliviar uno o más síntomas de una afeccion alérgica o inflamatoria en un paciente que necesite de dicho tratamiento o alivio de la afeccion; la forma galénica comprende una cantidad terapéuticamente efectiva de un descongestionante y un corticosteroide en una forma galénica unica adecuada para ser administrada por vía intranasal. Reivindicacion 40: La forma galénica de la reivindicacion 36, donde el descongestionante es xilometazolina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8099008P | 2008-07-15 | 2008-07-15 | |
| US11672108P | 2008-11-21 | 2008-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072805A1 true AR072805A1 (es) | 2010-09-22 |
Family
ID=41259574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102666A AR072805A1 (es) | 2008-07-15 | 2009-07-14 | Composiciones intranasales formas galenicas y metodos de tratamiento. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110189106A1 (es) |
| EP (1) | EP2318049A1 (es) |
| JP (1) | JP2011528355A (es) |
| KR (1) | KR20110045004A (es) |
| CN (1) | CN102159244A (es) |
| AR (1) | AR072805A1 (es) |
| AU (1) | AU2009271162A1 (es) |
| CA (1) | CA2730590A1 (es) |
| CO (1) | CO6331447A2 (es) |
| MX (1) | MX2011000590A (es) |
| RU (1) | RU2011101151A (es) |
| TW (1) | TW201016209A (es) |
| WO (1) | WO2010009028A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009302362A1 (en) * | 2008-10-10 | 2010-04-15 | Merck Sharp & Dohme Corp. | Corticosteroid compositions for use in treating diseases of the upper and lower airway passages |
| WO2013017821A1 (en) * | 2011-08-02 | 2013-02-07 | Cipla Limited | Pharmaceutical composition comprising ebastine and fluticasone |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
| CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| RU2686670C2 (ru) * | 2013-10-04 | 2019-04-30 | Гленмарк Спешиалити С.А. | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| JP6945614B2 (ja) * | 2014-03-26 | 2021-10-06 | オプティノーズ アズ | 経鼻投与 |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN106692115A (zh) * | 2015-11-13 | 2017-05-24 | 天津金耀集团有限公司 | 一种环索奈德混悬鼻喷剂组合物 |
| WO2019059953A2 (en) | 2017-09-22 | 2019-03-28 | Otitopic Inc. | DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN112006987B (zh) * | 2019-12-13 | 2023-04-28 | 吉林省健敷鼻科技有限公司 | 一种治疗鼻炎的冷敷凝胶及其之制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040053902A1 (en) * | 2002-09-13 | 2004-03-18 | Smith C. Steven | Novel composition and method for treatment of upper respiratory conditions |
| US20040191176A1 (en) * | 2003-03-28 | 2004-09-30 | Kaplan Leonard W | Formulations for treatment of pulmonary disorders |
| US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
| US7902177B2 (en) * | 2005-05-02 | 2011-03-08 | Wandzel Richard A | Treatment of congestion using steroids and adrenergics |
| US20100099650A1 (en) * | 2006-10-10 | 2010-04-22 | Knauer Kent A | Nasal spray composition and method for treating rhinitis, sinusitis or both |
-
2009
- 2009-07-13 CA CA2730590A patent/CA2730590A1/en not_active Abandoned
- 2009-07-13 AU AU2009271162A patent/AU2009271162A1/en not_active Abandoned
- 2009-07-13 CN CN2009801361292A patent/CN102159244A/zh active Pending
- 2009-07-13 JP JP2011518814A patent/JP2011528355A/ja not_active Withdrawn
- 2009-07-13 KR KR1020117003428A patent/KR20110045004A/ko not_active Withdrawn
- 2009-07-13 WO PCT/US2009/050361 patent/WO2010009028A1/en not_active Ceased
- 2009-07-13 RU RU2011101151/15A patent/RU2011101151A/ru not_active Application Discontinuation
- 2009-07-13 EP EP09790322A patent/EP2318049A1/en not_active Withdrawn
- 2009-07-13 MX MX2011000590A patent/MX2011000590A/es not_active Application Discontinuation
- 2009-07-13 US US13/054,242 patent/US20110189106A1/en not_active Abandoned
- 2009-07-14 TW TW098123785A patent/TW201016209A/zh unknown
- 2009-07-14 AR ARP090102666A patent/AR072805A1/es unknown
-
2011
- 2011-01-17 CO CO11004272A patent/CO6331447A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110045004A (ko) | 2011-05-03 |
| US20110189106A1 (en) | 2011-08-04 |
| CO6331447A2 (es) | 2011-10-20 |
| EP2318049A1 (en) | 2011-05-11 |
| JP2011528355A (ja) | 2011-11-17 |
| CN102159244A (zh) | 2011-08-17 |
| CA2730590A1 (en) | 2010-01-21 |
| MX2011000590A (es) | 2011-03-01 |
| RU2011101151A (ru) | 2012-07-20 |
| AU2009271162A1 (en) | 2010-01-21 |
| WO2010009028A1 (en) | 2010-01-21 |
| TW201016209A (en) | 2010-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072805A1 (es) | Composiciones intranasales formas galenicas y metodos de tratamiento. | |
| BRPI0915386B8 (pt) | Dispositivo para aplicação de um agente ativo através de mucosa | |
| MX2007011772A (es) | Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas. | |
| HK1199726A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| EA201491358A1 (ru) | Вводимые перорально кортикостероидные композиции | |
| PE20121396A1 (es) | Composicion farmaceutica que comprende bromuro de glicopirronio y formoterol | |
| PH12012501480A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| HK1198619A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| WO2009142772A3 (en) | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases | |
| MX2015017307A (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington. | |
| ATE535257T1 (de) | Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin | |
| UY30901A (es) | Nuevos metodos | |
| WO2009109613A3 (en) | 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 | |
| EA200800007A1 (ru) | Фармацевтические композиции на основе нейроактивного стероида и их применение | |
| PH12014500371A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
| AR093182A1 (es) | Metodo para tratar el sobrepeso o la obesidad | |
| CL2008003201A1 (es) | Composicion farmaceutica que comprende 0,5 a 50 mg de gaboxadol o una sal farmaceuticamente aceptable de este, y uno o mas inhibidores de pat1 y/o uno o mas inhibidores de oat, en donde dicha composicion brinda un perfil plasmatico in vivo con un tmax superior a 20 minutos, util en tratamientos de trastornos del sueno. | |
| MX383752B (es) | Forma de dosificación oral de liberación sostenida gastro retentiva de un secuestrante de ácido biliar. | |
| PE20191240A1 (es) | Formas de administracion farmaceutica que contienen inhibidores de canales task-1 y task-3 y su uso para el tratamiento de trastornos respiratorios | |
| EA201170405A1 (ru) | Монотерпены для лечения заболеваний дыхательных путей, в частности, бронхолегочных заболеваний | |
| ATE505477T1 (de) | Amorphe form von (11beta,16alpha)-9-fluoro-11- | |
| AR061618A1 (es) | Formas de dosificacion unitaria de temozolomida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |